依赖PARP-1的细胞死亡途径 (Parthanatos) 在下大脑关节出血后调解早期脑损伤
Yuwei Han1, Chenchen Wang1, Xiaoming Li1
1Institute of Neurology, General Hospital of Northern Theater Command, China.
European journal of pharmacology
|June 21, 2024
概括
一种新型的多 (ADP-ribose) 聚合酶1 (PARP-1) 抑制剂在治疗下关节出血 (SAH) 中显示出有前途. 这种药物减少了氧化应激,神经元亡,并改善了老鼠的神经功能,这表明SAH的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞死亡途径 细胞死亡途径
背景情况:
- 脑下关节下出血 (SAH) 是一种严重的神经疾病,治疗选择有限,死亡率高.
- 聚 (ADP-ribose) 聚合酶1 (PARP-1) 依赖的细胞死亡途径,称为帕萨纳托斯,与中风病理生理学有关.
- 对SAH有效的治疗策略仍然是一个关键的未满足的医疗需求.
研究的目的:
- 在SAH的老鼠模型中研究PARP-1抑制剂 (AG14361) 的治疗潜力.
- 评估PARP-1抑制对神经功能,氧化应激,血脑屏障完整性和帕尔他纳托斯通路激活的影响.
- 阐明PARP-1抑制可能有利于SAH的潜在机制.
主要方法:
- 在大鼠中诱导了SAH,随后是内注射PARP-1抑制剂AG14361.1.
- 评估了神经功能,并测量了氧化应激的生化标志物 (氨酸,8-基-2'-脱氧氨酸).
- 使用免疫光染色分析了与帕尔塔纳托斯相关的蛋白质的表达,包括诱导亡因子 (AIF).
- 还评估了与炎症相关的蛋白质和神经元亡的水平.
主要成果:
- 诱导SAH导致细胞核中与甲状腺相关的蛋白质和AIF的表达增加.
- PARP-1 抑制剂治疗显著降低了马隆迪阿尔海德水平和与帕坦阿托斯相关的蛋白质表达.
- 抑制剂降低了氧化应激标志物 (8-OHdG) 和与炎症相关的蛋白质.
- 服用PARP-1抑制剂改善了神经功能,保护了血脑屏障,并减少了神经元亡.
结论:
- PARP-1 抑制剂 AG14361 在SAH的老鼠模型中显示出显著的治疗益处.
- 保护效应很可能是通过抑制甲状腺炎路径来介导的.
- 准PARP-1代表了治疗下大脑关节出血的一个有希望的策略.
相关概念视频
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...